NCT03540433

Brief Summary

The purpose of this international, multi-centre observational study is to describe perioperative cognitive changes (pre-existing neurocognitive disorder \[NCD\], postoperative delirium \[POD\] and Postoperative Cognitive Dysfunction \[POCD\]) up to five years after elective surgery in a mixed cohort. Measurements and definitions of cognitive outcomes will be based on current consensus and used for further harmonization in future clinical studies on perioperative cognitive trajectories. This is a feasibility approach to identify an effective screening procedure and estimate loss to follow up rates for the planning of future intervention studies. Data from this trial may also serve to facilitate and implement time effective cognitive screening and risk stratification concerning postoperative cognitive decline in the anaesthesiological preoperative assessment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2018

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 30, 2018

Completed
9 days until next milestone

Study Start

First participant enrolled

June 8, 2018

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 4, 2025

Status Verified

February 1, 2025

Enrollment Period

6.6 years

First QC Date

May 17, 2018

Last Update Submit

February 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative cognitive dysfunction (POCD)

    Neuropsychological testing

    Up to 1 year

Secondary Outcomes (61)

  • Incidence of postoperative cognitive dysfunction (POCD)

    Up to 5 years

  • Positive cognitive screening

    Up to 5 years

  • Mild Neurocognitive Disorder

    Up to five years

  • Major Neurocognitive Disorder

    Up to five years

  • Cerobrospinal fluid biomarker for diagnosing dementia

    Up to five years

  • +56 more secondary outcomes

Other Outcomes (11)

  • Obesity 1

    At the beginning of the observation

  • Obesity 2

    At the beginning of the observation

  • Variables of adjusting

    At the beginning of the observation

  • +8 more other outcomes

Study Arms (2)

Study group

Surgical patients aged ≥70 years

Control group

Healthy subjects, aged ≥70 years, American Society of Anesthesiologists (ASA) I+II+III, no surgery

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Surgical patients aged ≥70 years

You may qualify if:

  • Surgical patients at Campus Virchow- Klinikum and Campus Charité Mitte
  • Aged ≥ 70 years
  • Informed consent

You may not qualify if:

  • Manifest dementia
  • Lack of willingness to store and disseminate pseudonymized disease data as part of the clinical trial
  • Lack of readiness to participate in the follow-up examinations and contact to make an appointment
  • Placement in an institute under judicial or official orders (according to German drug Law §40 (1) 4)
  • Persons without a permanent residence or other circumstances that call into question the availability by telephone or post for postoperative examination
  • Employees of the respective study centers
  • illiteracy
  • Patients with a neuropsychiatric condition that limits the performance of neurocognitive testing
  • Patients with hearing and / or vision problems that limit the performance of neuro-cognitive testing
  • Simultaneous participation in a prospective clinical intervention study (apart from the desired parallel participation in the anaesthesiological study Praep-Go, EA1/225/19)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Arbeitsbereich Physikalische Medizin

Berlin, 10117, Germany

Location

Internistische Hausarztpraxis

Berlin, 12163, Germany

Location

Department of Anesthesiology and Intensive Care Medicine Berlin (CCM/CVK), Charité - Universitätsmedizin Berlin

Berlin, 13353, Germany

Location

MeSH Terms

Conditions

Neurocognitive Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK)

Study Record Dates

First Submitted

May 17, 2018

First Posted

May 30, 2018

Study Start

June 8, 2018

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

February 4, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations